Ex vivo expansion of human T cells for adoptive immunotherapy using the novel Xeno-free CTS Immune Cell Serum Replacement

The manufacture of clinical grade cellular products for adoptive immunotherapy requires ex vivo culture and expansion of human T cells. One of the key components in manufacturing of T cell therapies is human serum (HS) or fetal bovine serum (FBS), which can potentially expose immunotherapy recipient...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Corey, Økern, Grethe, Rehan, Sweera, Beagley, Leone, Lee, Sau K, Aarvak, Tanja, Schjetne, Karoline W, Khanna, Rajiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318490/
https://www.ncbi.nlm.nih.gov/pubmed/25671129
http://dx.doi.org/10.1038/cti.2014.31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318490/
https://www.ncbi.nlm.nih.gov/pubmed/25671129
http://dx.doi.org/10.1038/cti.2014.31

Ejemplares similares